A Phase I/II Study of Sirolimus in Addition to Tacrolimus and Methotrexate for the Prevention of Acute-Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation From Unrelated Donors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Methotrexate; Sirolimus; Tacrolimus
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 15 Jul 2011 Biomarkers information updated
- 27 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2005 New trial record.